Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blackstone Group, Inc.

https://www.blackstone.com/

Latest From Blackstone Group, Inc.

The Biopharma A List: Taking The Pulse Of Newco Creation

The market for new company creation in the biopharma sector remains healthy and poised to continue fostering the establishment of start-ups, based on a new In Vivo study of the strong initial investments that pharma and biotech companies receive.

StartUps and SMEs Financing

Sanofi Challenges J&J’s Darzalex With Blackstone Pact For SC Sarclisa

The French major has entered a risk-sharing collaboration with Blackstone focused on a new formulation of multiple myeloma drug Sarclisa, which could help it take on market leader Darzalex.

Deals Cancer

Takeda Expects Stronger Net Profit On Lower Tax

Entyvio strong again for Japanese firm as it raises net profit forecast on lower tax costs. Meanwhile, 'Wave 1' pipeline projects are progressing, with simultaneous development in major markets a key goal. 

Commercial Business Strategies

Another Divestment By Takeda, To China’s Hasten For $322m

Japanese major sheds further non-core assets as it continues to focus on innovation and pay down debt following the Shire acquisition.

China Commercial
See All

Company Information

  • Industry
  • Miscellaneous
  • Other Names / Subsidiaries
    • The Blackstone Group Inc
    • The Blackstone Group L.P
UsernamePublicRestriction

Register